Murai-Kushiya M, Okada S, Kimura T, Hasegawa R
National Institute of Hygienic Sciences, Osaka Branch, Japan.
J Pharm Pharmacol. 1993 Sep;45(9):836-8. doi: 10.1111/j.2042-7158.1993.tb05696.x.
Turpentine oil treatment (0.2 mL kg-1, s.c.) was used to increase the plasma concentration of alpha 1-acid glycoprotein (0.13 mg mL-1 in control rats) to 1.72 mg mL-1 after 2 days, and allow assessment of its effects on the pharmacokinetics and stereoselective binding of three beta-blockers. Racemates (5 mg kg-1) were administered intravenously to control and turpentine oil-pretreated rats and the plasma concentrations were determined up to 90 min. Stereoselective analysis showed the apparent distribution volume and the area under plasma concentration-time curves (AUC) of R-(+)-propranolol to be, respectively, one-quarter and twice those of the S-(-)-enantiomer and differences in pharmacokinetic parameters between the two were magnified by turpentine oil pretreatment. Pharmacokinetic parameters of oxprenolol enantiomers were essentially similar for the controls but after turpentine oil pretreatment, a higher affinity of the R-(+)-enantiomer for plasma was observed. Acebutolol enantiomers behaved non-stereospecifically throughout. These results were consistent with predictions from the in-vitro stereospecific binding properties of these agents to purified rat alpha 1-acid glycoprotein.
松节油治疗(0.2 mL kg-1,皮下注射)用于将α1-酸性糖蛋白的血浆浓度(对照大鼠中为0.13 mg mL-1)在2天后提高至1.72 mg mL-1,并评估其对三种β受体阻滞剂的药代动力学和立体选择性结合的影响。将外消旋体(5 mg kg-1)静脉注射给对照大鼠和经松节油预处理的大鼠,并在长达90分钟内测定血浆浓度。立体选择性分析表明,R-(+)-普萘洛尔的表观分布容积和血浆浓度-时间曲线下面积(AUC)分别是S-(-)-对映体的四分之一和两倍,并且松节油预处理放大了两者之间药代动力学参数的差异。对照中氧烯洛尔对映体的药代动力学参数基本相似,但经松节油预处理后,观察到R-(+)-对映体对血浆具有更高的亲和力。醋丁洛尔对映体在整个过程中表现出非立体特异性。这些结果与这些药物对纯化的大鼠α1-酸性糖蛋白的体外立体特异性结合特性的预测一致。